Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

SIGNIFICANCE: The α(2)-adrenergic receptor agonist brimonidine has been reported to induce conjunctival blanching in cataract, strabismus, laser refractive, and filtration procedures. Clinicians are often faced with red eyes with no apparent underlying pathology. Low-dose brimonidine reduced ocular...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaurin, Eugene, Cavet, Megan E., Gomes, Paul J., Ciolino, Joseph B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839712/
https://www.ncbi.nlm.nih.gov/pubmed/29461408
http://dx.doi.org/10.1097/OPX.0000000000001182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839712/
https://www.ncbi.nlm.nih.gov/pubmed/29461408
http://dx.doi.org/10.1097/OPX.0000000000001182

Ejemplares similares